Search by Drug Name or NDC

    NDC 64980-0235-01 Metronidazole 250 mg/1 Details

    Metronidazole 250 mg/1

    Metronidazole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is METRONIDAZOLE.

    Product Information

    NDC 64980-0235
    Product ID 64980-235_0e31a067-d128-4d12-8e76-84cb2519ca3a
    Associated GPIs 16000035000305
    GCN Sequence Number 009591
    GCN Sequence Number Description metronidazole TABLET 250 MG ORAL
    HIC3 W4E
    HIC3 Description ANAEROBIC ANTIPROTOZOAL-ANTIBACTERIAL AGENTS
    GCN 43031
    HICL Sequence Number 004157
    HICL Sequence Number Description METRONIDAZOLE
    Brand/Generic Generic
    Proprietary Name Metronidazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Metronidazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name METRONIDAZOLE
    Labeler Name Rising Pharmaceuticals, Inc.
    Pharmaceutical Class Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205245
    Listing Certified Through 2024-12-31

    Package

    NDC 64980-0235-01 (64980023501)

    NDC Package Code 64980-235-01
    Billing NDC 64980023501
    Package 100 TABLET in 1 BOTTLE (64980-235-01)
    Marketing Start Date 2016-02-22
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL bf82510d-3327-429a-9da2-6ebd7d849e36 Details

    Revised: 12/2017